NovaBridge Biosciences

NovaBridge Biosciencesverified

NBP

Price:

$3.99

Market Cap:

$3.25B

NovaBridge Biosciences, a biotech company, focuses on the development of immuno-oncology agents for the treatment of cancer in the United States. The company is developing givastomig, a bispecific antibody, which is in Phase 1b clinical trial for the treatment of gastric cancer; uliledlimab, a CD73 neutralizing antibody; and ragistomig, a bispecific antibody, which is in phase 1 clinical trial for the treatment of solid tumors. It has a strategic licensing agreement with Ferring International Center SA to research, develop, make, have made, import, use, sell, and offer to sell FE301, an interleukin-6 inhibitor. The company also has collaborations with Bristol Myers Squibb for the development...[Read more]

Industry

Biotechnology

IPO Date

2020-01-17

Stock Exchange

NASDAQ

Ticker

NBP

The Enterprise Value as of December 2025 (TTM) for NovaBridge Biosciences (NBP) is 3.09B

According to NovaBridge Biosciences’s latest financial reports and current stock price. The company's current Enterprise Value is 3.09B. This represents a change of 1.69% compared to the average of 172.89M of the last 4 quarters.

NovaBridge Biosciences (NBP) Historical Enterprise Value (quarterly & annually)

How has NBP Enterprise Value performed in the past?

The mean historical Enterprise Value of NovaBridge Biosciences over the last ten years is 5.78B. The current 3.09B Enterprise Value has changed 5.24% with respect to the historical average. Over the past ten years (40 quarters), NBP's Enterprise Value was at its highest in in the June 2021 quarter at 35.49B. The Enterprise Value was at its lowest in in the September 2023 quarter at -1264580417.51.

Quarterly (TTM)
Annual

Average

5.78B

Median

3.81B

Minimum

-885726356.66

Maximum

19.45B

NovaBridge Biosciences (NBP) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of NovaBridge Biosciences Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 300.57%

Maximum Annual Enterprise Value = 19.45B

Minimum Annual Increase = -104.10%

Minimum Annual Enterprise Value = -885726356.66

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20244.63M-100.52%
2023-885726356.6611.17%
2022-796748604.48-104.10%
202119.45B19.66%
202016.25B300.57%
20194.06B14.02%
20183.56B-23.25%

NovaBridge Biosciences (NBP) Average Enterprise Value

How has NBP Enterprise Value performed in the past?

The current Enterprise Value of NovaBridge Biosciences (NBP) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-559282595.74

5-year avg

6.80B

10-year avg

5.78B

NovaBridge Biosciences (NBP) Enterprise Value vs. Peers

How is NBP’s Enterprise Value compared to its peers?

NovaBridge Biosciences’s Enterprise Value is greater than Galectin Therapeutics Inc. (516.38M), greater than Design Therapeutics, Inc. (540.75M), greater than DiaMedica Therapeutics Inc. (445.61M), greater than Aura Biosciences, Inc. (320.33M), greater than Rocket Pharmaceuticals, Inc. (319.22M), greater than Annexon, Inc. (432.32M), greater than Alpha Tau Medical Ltd. (356.31M), greater than LB Pharmaceuticals Inc Common Stock (467.73M), greater than enGene Holdings Inc. (396.46M), greater than Altimmune, Inc. (407.41M),

Build a custom stock screener for NovaBridge Biosciences (NBP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NovaBridge Biosciences using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NovaBridge Biosciences (NBP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NovaBridge Biosciences or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is NovaBridge Biosciences's Enterprise Value?

What is the highest Enterprise Value for NovaBridge Biosciences (NBP)?

What is the 3-year average Enterprise Value for NovaBridge Biosciences (NBP)?

What is the 5-year average Enterprise Value for NovaBridge Biosciences (NBP)?

How does the current Enterprise Value for NovaBridge Biosciences (NBP) compare to its historical average?